Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alphaL Canobbio, A Rubagotti, L Miglietta, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancerM T Nobile, M R Sertoli, M Bruzzone, et al.
The International Journal of Biological Markers|July 19, 2006
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patientsF Boccardo, A Rubagotti, M Battaglia, et al.
Oncology|January 1, 1987
Adjuvant immunochemotherapy in colorectal cancer Dukes CM R Sertoli, D Guarneri, A Rubagotti, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1990
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapyE Campora, E Baldini, A Rubagotti, et al.
Tumori|December 31, 1982
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancerR Rosso, M T Nobile, F Brema, et al.
Gynecologic Oncology|March 1, 1985
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerP F Conte, M R Sertoli, M Bruzzone, et al.
Gynecologic Oncology|April 1, 1993
Cerebral metastases secondary to ovarian cancer: still an unusual eventM Bruzzone, E Campora, S Chiara, et al.
American Journal of Clinical Oncology|February 1, 1993
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensityP Pronzato, L Miglietta, A Rubagotti, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Pageof 7